Brain Dopamine – Clock Interactions Regulate Cardiometabolic Health in T2D
http://www.diabetesincontrol.com/brain-dopamine-clock-interactions-regulate-cardiometabolic-health-in-t2d/
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
http://www.diabetesincontrol.com/brain-dopamine-clock-interactions-regulate-cardiometabolic-health-in-t2d/
https://www.wcir.org/
http://www.metabesity2019.com/
https://www.clevelandclinicmeded.com/live/courses/endo/
https://www.aace.com/chapters/new-england
https://www.endocrine.org/ceu
https://www.prnewswire.com/news-releases/veroscience-presents-new-pipeline-data-for-metabolic-disease-therapies-at-2019-american-diabetes-association-meeting-300864258.html
https://www.streetinsider.com/Press+Releases/VeroScience+is+Pleased+to+Support+Independent+Research+from+the+Laboratory+of+Dr.+DeFronzo+and+Team+at+UT+Health+Science+Center,+San+Antonio/11731961.html
https://www.prnewswire.com/news-releases/veroscience-continues-to-explore-clinical-benefits-of-circadian-neuroendocrine-resetting-therapy-with-six-papers-presented-at-2016-american-diabetes-association-scientific-sessions-june-10-14-300283267.html
http://medcitynews.com/2015/08/can-deconstructing-the-biological-clock-help-treat-diabetes-and-cancer/
